share_log

Viracta Therapeutics | 10-K: Annual report

SEC ·  Mar 17, 2022 07:21
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.